Remove 2023 Remove Clinic Remove Diagnostic Imaging Remove Radiation Oncology
article thumbnail

The rise of theranostics: Part 5 -- Advice from center administrators

AuntMinnie

As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. The theranostics tumor board at WU is part of a larger collaboration between the disciplines of nuclear medicine and radiation oncology.

article thumbnail

RefleXion Highlights Clinical Study Results for Future Prostate Cancer Treatment

Imaging Technology

milla1cf Mon, 07/03/2023 - 20:06 July 3, 2023 — RefleXion Medical , Inc., professor of the Department of Radiation Oncology and the Department of Immunology and Theranostics at City of Hope , and principal investigator of the RefleXion-supported PyL imaging study.

Clinic 73
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

TTG Imaging Solutions Acquires Digirad Health from Star Equity Holdings

TTG Imaging Solutions

Enhances TTG’s continued commitment to offer a full spectrum of high-quality and cost-effective service solutions in the cardiology and radiation oncology markets PITTSBURGH, PA (May 5, 2023) – TTG Imaging Solutions, LLC (TTG) announced today the acquisition of Digirad Health, Inc., The acquisition closed on May 4, 2023.

Imaging 52
article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.

article thumbnail

Additional Results of POSLUMA (Flotufolastat F 18) Performance in Newly Diagnosed, High-risk Prostate Cancer Patients Presented at ASTRO

Imaging Technology

Effective initial staging of prostate cancer, particularly with regards to the detection of metastatic disease, is critical to optimal clinical management of patients,” said Phillip H. Kuo, MD, Ph.D. , Departments of Medical Imaging, Medicine, and Biomedical Engineering. Chief Executive Officer of Blue Earth Diagnostics.

article thumbnail

GE HealthCare Introduces Innovations to Improve Radiation Therapy Efficiency and Precision Care at the European Society for Therapeutic Radiology and Oncology 2023 Congress

Imaging Technology

milla1cf Mon, 05/15/2023 - 10:26 May 15, 2023 — GE HealthCare is presenting three new global innovations – Intelligent Radiation Therapy (iRT), Auto Segmentation, and an updated Magnetic Resonance (MR) Radiation Therapy Suite (AIR Open Coil Suite) – that underscore the company’s commitment to enhancing the radiation oncology care pathway.